Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.
about
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.The dual role of complement in cancer and its implication in anti-tumor therapyThe Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionIdentification and analysis of tumour-associated antigens in hepatocellular carcinoma.Self-nonself discrimination by the complement system.Complement factor H autoantibodies are associated with early stage NSCLC.Complement control protein factor H: the good, the bad, and the inadequate.Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseComplement activation in astrocytomas: deposition of C4d and patient outcomeDiscovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasisThe role of complement in tumor growthThe immunohistochemical analysis of membrane-bound CD55, CD59 and fluid-phase FH and FH-like complement inhibitors in cancers of ovary and corpus uteri origin.Complement factor H polymorphism rs1061170 and the effect of cigarette smoking on the risk of lung cancer.Ascitic complement system in ovarian cancerSecretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells.A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.The C-terminus of complement factor H is essential for host cell protection.Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells.Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.Complement in cancer and cancer immunotherapy.Role of C5b-9 complement complex and response gene to complement-32 (RGC-32) in cancer.Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc.A protein with characteristics of factor H is present on rodent platelets and functions as the immune adherence receptor.Complementing the Sugar Code: Role of GAGs and Sialic Acid in Complement RegulationBinding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.Innate immune mediators in cancer: between defense and resistance.Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA).Properdin and factor h: opposing players on the alternative complement pathway "see-saw".The possible role of factor H in colon cancer resistance to complement attack.Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy.The effect of dexamethasone on human mucin 1 expression and antibody-dependent complement sensitivity in a prostate cancer cell line in vitro and in vivo.The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.C1-inactivator is upregulated in glioblastoma.Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity.Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells.The contemporary role and impact of urine-based biomarkers in bladder cancer.Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid.Deficiency of the human complement regulatory protein factor H associated with low levels of component C9.
P2860
Q24543850-7FBA4E16-355B-4524-87DC-AE5BCA4B626BQ26738682-462C8811-F64D-4162-8551-E267C4F38E00Q26750877-E73591B1-E465-4B54-904E-350B251CAC06Q33212678-7B008227-247E-4720-9286-CC93B1A776A6Q33433754-A38ED9BB-2BB7-44FA-B058-2CF51780213DQ33937882-D9EFF96B-99A6-41F5-88F7-59F2CF988021Q34067107-B8089E93-6992-4ADC-8C8C-C2757D1C0E7AQ34464343-751E1BA8-0BB7-453F-B546-0B23620CE8F6Q34496822-EF722BB9-0E42-4595-ACD5-DD3234DAB7C2Q35006575-569BCF0B-60E2-443C-808A-FF88E69BFE20Q35231345-B5189A65-7F8D-480E-9727-AE929D56CFADQ36305634-3397C335-410A-464B-A15C-3D7D1A110F5EQ36516055-5F46E6D7-F8FC-4031-B8E2-7D5F86A87FFAQ36616364-420FB3F8-E29A-49C0-AFB4-CAFA32B9465DQ36646213-C48922BF-B1B7-45A7-914C-F0A48D03269FQ36913660-85E9941A-20D1-40AB-BB41-3EABE5FF6824Q37238656-6DB181FD-F015-406E-BD31-1345A6131969Q37377923-2494FB77-8E0B-4212-B89F-600C559F574DQ37496310-38A0C256-8AA6-439F-906D-F1800F07A47FQ37940918-5B26CCCC-9F70-4106-ABF6-3EE6ADD76B40Q38068141-421CFEAD-B1FD-44C9-8FE7-21F77F3B9273Q38223669-F1E3B97E-8F82-43CC-985A-00139C81B0E5Q38291696-32328FEC-45D2-42C9-B19B-D3E06C81A836Q38292615-48677458-E9C3-415C-9A81-89E8BB572B85Q38299951-19EFBABB-1C25-4BA5-92A4-10388CD0C461Q38362621-2348A0AF-697D-4317-A7F3-CF8DC3E004C7Q38596477-501B5F46-0652-4362-8AE0-27167A1C4E4FQ38991015-7BB964AA-E0D8-47B8-84B1-83CF198F6A0CQ39012599-C7B5F383-FBC2-40CB-82E4-368FEACE5685Q39158331-92DA5A91-870F-42BE-860B-C6618BAB7B94Q40027080-3BFF5B2F-E4E1-49EA-8801-DFF52AFFDCF8Q40287396-B42C86E3-3B4B-45A1-B37D-A01CA8823B9AQ40580730-6E9B10D7-276B-40C6-BD8F-79E6165EC1D1Q40715358-91B67FDA-BA5F-464A-B1BD-F7B80A910FF9Q41577019-E7B95FA8-8B40-4FE7-88E8-CB5CE98F7AE5Q41966008-C3C0F639-8092-4061-9489-DB4DEFEDEF17Q44381847-CEB46932-28EA-41F5-A652-4DFFF303432DQ47721208-A438C880-859A-4EAF-9354-F0072C286AC9Q53942590-0D3AF781-4116-43E5-8DC1-2C09E3938F8EQ54516563-91735B2F-9342-474B-8D2D-ED0F02FC1038
P2860
Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Exceptional resistance of huma ...... H and factor H-like protein 1.
@en
Exceptional resistance of huma ...... H and factor H-like protein 1.
@nl
type
label
Exceptional resistance of huma ...... H and factor H-like protein 1.
@en
Exceptional resistance of huma ...... H and factor H-like protein 1.
@nl
prefLabel
Exceptional resistance of huma ...... H and factor H-like protein 1.
@en
Exceptional resistance of huma ...... H and factor H-like protein 1.
@nl
P2093
P1476
Exceptional resistance of huma ...... H and factor H-like protein 1.
@en
P2093
P304
P356
10.4049/JIMMUNOL.164.11.6075
P407
P577
2000-06-01T00:00:00Z